| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNMB2 CACNA1E PANX1 SLC1A3 SLC1A6 RYR2 RYR3 ATP2C1 SCN1A SCN2A SCN3A SCN5A | 1.30e-05 | 465 | 113 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.32e-05 | 26 | 113 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion binding | 6.14e-05 | 14 | 113 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | calcium ion binding | CACNA1E CABP5 PCDHGB3 S100A7L2 ASAH2 EFHD2 ACTN3 RYR2 RYR3 MYOF ATP2C1 ITSN2 PITPNM3 AIF1 | 8.53e-05 | 749 | 113 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | actin binding | HDAC6 SPATA31A3 SYNE1 SPATA31A7 TMOD3 PANX1 ACTN3 SPATA31A6 SPATA31A5 SPATA31A1 AIF1 | 8.69e-05 | 479 | 113 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.46e-04 | 343 | 113 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.72e-04 | 206 | 113 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.89e-04 | 4 | 113 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.13e-04 | 52 | 113 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | KCNMB2 CACNA1E PANX1 SLC1A3 SLC1A6 RYR2 RYR3 ATP2C1 SCN1A SCN2A SCN3A SCN5A | 2.27e-04 | 627 | 113 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 3.14e-04 | 5 | 113 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 3.14e-04 | 5 | 113 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 3.48e-04 | 59 | 113 | 4 | GO:0031593 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNMB2 CACNA1E PANX1 SLC1A3 SLC1A6 RYR2 RYR3 ATP2C1 SCN1A SCN2A SCN3A SCN5A | 3.82e-04 | 664 | 113 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.17e-04 | 26 | 113 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.28e-04 | 171 | 113 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HDAC6 SPATA31A3 RTCB KIF26B SYNE1 SPATA31A7 EML6 TMOD3 PANX1 ACTN3 SPATA31A6 SPATA31A5 SPATA31A1 SCN5A AIF1 KIF3C | 4.58e-04 | 1099 | 113 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.69e-04 | 6 | 113 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.20e-03 | 459 | 113 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | KCNMB2 CACNA1E PANX1 SLC1A3 SLC1A6 RYR2 RYR3 ATP2C1 SCN1A SCN2A SCN3A SCN5A | 1.22e-03 | 758 | 113 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.69e-03 | 151 | 113 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | KCNMB2 CACNA1E PANX1 SLC1A3 SLC1A6 RYR2 RYR3 ATP2C1 SCN1A SCN2A SCN3A SCN5A | 1.78e-03 | 793 | 113 | 12 | GO:0015075 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.13e-06 | 62 | 113 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.77e-06 | 112 | 113 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 8.33e-06 | 87 | 113 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.22e-05 | 93 | 113 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 2.46e-05 | 63 | 113 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.62e-05 | 217 | 113 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.39e-05 | 36 | 113 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | muscle contraction | 7.08e-05 | 400 | 113 | 10 | GO:0006936 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 7.14e-05 | 127 | 113 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | action potential | 1.21e-04 | 201 | 113 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ILK HDAC6 TMOD3 ACTN3 PIP5K1C RYR2 ARF6 GPD1L ATP2C1 ABI2 SCN1A SCN2A SCN3A SCN5A AIF1 | 1.36e-04 | 912 | 113 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 1.86e-04 | 96 | 113 | 5 | GO:0048488 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.99e-04 | 153 | 113 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle system process | TMOD3 ACTN3 RYR2 RYR3 GPD1L MYOF SCN1A SCN2A SCN3A SCN5A AIF1 | 2.09e-04 | 547 | 113 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 2.46e-04 | 102 | 113 | 5 | GO:0140238 | |
| GeneOntologyCellularComponent | sarcomere | 1.20e-06 | 249 | 115 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.96e-06 | 17 | 115 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | myofibril | 2.74e-06 | 273 | 115 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.68e-06 | 290 | 115 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.86e-05 | 29 | 115 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | acrosomal vesicle | SPATA31A3 SPATA31A7 SH3GL3 SPATA31A6 SPATA31A5 SPATA31A1 MROH2B DPEP3 | 1.86e-05 | 206 | 115 | 8 | GO:0001669 |
| GeneOntologyCellularComponent | Z disc | 2.04e-05 | 151 | 115 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | supramolecular fiber | ILK HDAC6 DNAH10 KIF26B SYNE1 FBF1 BAG3 EML6 TMOD3 ACTN3 RYR2 RYR3 KLHL22 ABI2 UNC45B SCN1A SCN5A AIF1 KIF3C | 2.25e-05 | 1179 | 115 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | ILK HDAC6 DNAH10 KIF26B SYNE1 FBF1 BAG3 EML6 TMOD3 ACTN3 RYR2 RYR3 KLHL22 ABI2 UNC45B SCN1A SCN5A AIF1 KIF3C | 2.47e-05 | 1187 | 115 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | I band | 3.74e-05 | 166 | 115 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | cation channel complex | 4.77e-05 | 235 | 115 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.17e-03 | 378 | 115 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | presynapse | CACNA1E ILK BTBD8 SH3GL3 SCRN1 PIP5K1C SLC1A6 ARF6 MYOF SCN1A SCN2A ITSN2 KIF3C | 1.18e-03 | 886 | 115 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | plasma membrane raft | 1.33e-03 | 147 | 115 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.58e-03 | 591 | 115 | 10 | GO:0005911 | |
| MousePheno | ventricular fibrillation | 9.17e-06 | 7 | 91 | 3 | MP:0006110 | |
| Domain | Na_trans_cytopl | 1.82e-08 | 6 | 112 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 1.82e-08 | 6 | 112 | 4 | IPR024583 | |
| Domain | Na_channel_asu | 2.50e-07 | 10 | 112 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 2.50e-07 | 10 | 112 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 2.50e-07 | 10 | 112 | 4 | PF06512 | |
| Domain | DUF4599 | 5.84e-07 | 12 | 112 | 4 | PF15371 | |
| Domain | DUF4599 | 5.84e-07 | 12 | 112 | 4 | IPR027970 | |
| Domain | Ion_trans_dom | 5.60e-06 | 114 | 112 | 7 | IPR005821 | |
| Domain | Ion_trans | 5.60e-06 | 114 | 112 | 7 | PF00520 | |
| Domain | EF-hand-dom_pair | 8.94e-06 | 287 | 112 | 10 | IPR011992 | |
| Domain | EF_HAND_2 | 1.06e-05 | 231 | 112 | 9 | PS50222 | |
| Domain | EF_hand_dom | 1.09e-05 | 232 | 112 | 9 | IPR002048 | |
| Domain | Channel_four-helix_dom | 2.32e-05 | 57 | 112 | 5 | IPR027359 | |
| Domain | - | 2.32e-05 | 57 | 112 | 5 | 1.20.120.350 | |
| Domain | Ryanodine_rcpt | 1.07e-04 | 3 | 112 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.07e-04 | 3 | 112 | 2 | IPR009460 | |
| Domain | RyR | 1.07e-04 | 3 | 112 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.07e-04 | 3 | 112 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.07e-04 | 3 | 112 | 2 | IPR013333 | |
| Domain | IQ | 1.26e-04 | 81 | 112 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.08e-04 | 90 | 112 | 5 | IPR000048 | |
| Domain | IQ | 2.42e-04 | 93 | 112 | 5 | PS50096 | |
| Domain | RIH_assoc-dom | 5.26e-04 | 6 | 112 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.26e-04 | 6 | 112 | 2 | PF08709 | |
| Domain | RIH_assoc | 5.26e-04 | 6 | 112 | 2 | PF08454 | |
| Domain | RIH_dom | 5.26e-04 | 6 | 112 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.26e-04 | 6 | 112 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.26e-04 | 6 | 112 | 2 | IPR015925 | |
| Domain | - | 5.26e-04 | 6 | 112 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 5.26e-04 | 6 | 112 | 2 | PF01365 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 7.34e-04 | 7 | 112 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 7.34e-04 | 7 | 112 | 2 | PS00714 | |
| Domain | SDF | 7.34e-04 | 7 | 112 | 2 | PF00375 | |
| Domain | - | 7.34e-04 | 7 | 112 | 2 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 7.34e-04 | 7 | 112 | 2 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 7.34e-04 | 7 | 112 | 2 | IPR018107 | |
| Domain | - | 1.00e-03 | 261 | 112 | 7 | 1.10.238.10 | |
| Domain | MBT | 1.25e-03 | 9 | 112 | 2 | SM00561 | |
| Domain | MBT | 1.25e-03 | 9 | 112 | 2 | PS51079 | |
| Domain | MIR | 1.55e-03 | 10 | 112 | 2 | PF02815 | |
| Domain | MBT | 1.55e-03 | 10 | 112 | 2 | PF02820 | |
| Domain | MIR_motif | 1.55e-03 | 10 | 112 | 2 | IPR016093 | |
| Domain | Mbt | 1.55e-03 | 10 | 112 | 2 | IPR004092 | |
| Domain | MIR | 1.55e-03 | 10 | 112 | 2 | PS50919 | |
| Domain | MIR | 1.55e-03 | 10 | 112 | 2 | SM00472 | |
| Domain | EF-hand_1 | 2.23e-03 | 152 | 112 | 5 | PF00036 | |
| Domain | EFh | 2.64e-03 | 158 | 112 | 5 | SM00054 | |
| Domain | ATPase_dyneun-rel_AAA | 3.09e-03 | 14 | 112 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.09e-03 | 14 | 112 | 2 | PF07728 | |
| Domain | Spectrin_alpha_SH3 | 3.56e-03 | 15 | 112 | 2 | IPR013315 | |
| Domain | ARM-type_fold | 4.35e-03 | 339 | 112 | 7 | IPR016024 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.27e-05 | 203 | 86 | 8 | M5485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47958 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.58e-05 | 31 | 86 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 4.08e-05 | 32 | 86 | 4 | M27455 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.41e-04 | 130 | 86 | 6 | M27454 | |
| Pubmed | 2.17e-12 | 6 | 115 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.17e-12 | 6 | 115 | 5 | 25930072 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 5.24e-09 | 168 | 115 | 9 | 30631154 | |
| Pubmed | 1.41e-08 | 9 | 115 | 4 | 16382098 | ||
| Pubmed | 1.41e-08 | 9 | 115 | 4 | 15746173 | ||
| Pubmed | 1.46e-08 | 24 | 115 | 5 | 32212159 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23859570 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 12610651 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18784617 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17544618 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 14973256 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 5.50e-08 | 12 | 115 | 4 | 30175250 | |
| Pubmed | 7.93e-08 | 13 | 115 | 4 | 15123669 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 17537961 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 35801810 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 35031483 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 29578003 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.41e-07 | 4 | 115 | 3 | 8974318 | |
| Pubmed | MYC CAAP1 MBTD1 HDAC6 VWA8 KDM5A FBF1 TMOD3 ZNF318 SIK3 DDB1 NKRF ATP2C1 TAF9B SCN5A CTNNBL1 CRYBG3 | 1.63e-07 | 1116 | 115 | 17 | 31753913 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 1679748 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 8812438 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 24337656 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 17724025 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC MIS18BP1 DIS3L2 ILK HDAC6 RTCB BAG3 WDR70 BMS1 RPSA BIRC6 DDB1 NKRF SRRT SBF1 CTNNBL1 DDX60L PCNA | 4.95e-07 | 1353 | 115 | 18 | 29467282 |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.99e-07 | 6 | 115 | 3 | 23652591 | |
| Pubmed | CACNA1E KDM5A SYNE1 EFHD2 ZNF318 SIK3 DDB1 TMEM132B SLC1A3 MAP3K5 SBF1 ABI2 MAD1L1 TNR GOLGB1 | 7.05e-07 | 963 | 115 | 15 | 28671696 | |
| Pubmed | 1.26e-06 | 103 | 115 | 6 | 10574462 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | VWA8 RBMS2 BAG3 BMS1 ZNF318 SIK3 NCLN DDB1 SLC1A3 ARF6 ATP2C1 GOLGB1 EIF4E2 | 1.35e-06 | 754 | 115 | 13 | 33060197 |
| Pubmed | CAAP1 MACC1 RTCB KDM5A SYNE1 MKRN1 BMS1 EFHD2 RPSA ZNF318 NKRF SRRT MYOF SBF1 ABI2 ITSN2 CTNNBL1 GOLGB1 | 2.09e-06 | 1497 | 115 | 18 | 31527615 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ILK HDAC6 RTCB RBMS2 BAG3 BMS1 EFHD2 RPSA GPRIN1 DDB1 PARP10 MYOF AARS2 CTNNBL1 MMUT GOLGB1 PCNA | 2.65e-06 | 1367 | 115 | 17 | 32687490 |
| Pubmed | DIS3L2 SYNE1 BAG3 TMOD3 SCRN1 RPSA NCLN ARF6 MYOF SCN2A DDX3Y PCNA GULP1 | 2.70e-06 | 803 | 115 | 13 | 36517590 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CAAP1 HDAC6 RTCB VWA8 KDM5A SYNE1 BMS1 RPSA SIK3 DDB1 NKRF SRRT SBF1 CTNNBL1 DDX3Y | 2.96e-06 | 1082 | 115 | 15 | 38697112 |
| Pubmed | ILK HDAC6 KIF26B RBMS2 MKRN1 TMOD3 EFHD2 RPSA ZNF318 SIK3 AARS2 SBF1 | 3.19e-06 | 689 | 115 | 12 | 36543142 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ILK HDAC6 RTCB VWA8 BAG3 EFHD2 RPSA NCLN BIRC6 DDB1 SLC1A3 PDCD4 SRRT CTNNBL1 GOLGB1 PCNA EIF4E2 | 4.19e-06 | 1415 | 115 | 17 | 28515276 |
| Pubmed | BTBD8 RTCB SYNE1 TMOD3 SCRN1 EFHD2 RPSA ACTN3 DDB1 SLC1A3 GPD1L SRRT SBF1 SCN2A ITSN2 DDX3Y TNR | 4.86e-06 | 1431 | 115 | 17 | 37142655 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ILK RTCB KDM5A KIF26B BAG3 SIK3 FSIP2 SRRT SBF1 MAD1L1 CRYBG3 GOLGB1 EIF4E2 | 5.74e-06 | 861 | 115 | 13 | 36931259 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PCDHGB3 KIF26B BMS1 PIWIL2 GPRIN1 BIRC6 TMEM132B SCN3A CTNNBL1 PITPNM3 EEF1AKMT1 TNR | 6.23e-06 | 736 | 115 | 12 | 29676528 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 7.20e-06 | 139 | 115 | 6 | 16985003 | |
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 8169823 | ||
| Pubmed | ASNSD1 RTCB VWA8 SYNE1 TMOD3 EFHD2 SLC1A6 MYOF ATP2C1 CTNNBL1 GOLGB1 PCNA | 7.94e-06 | 754 | 115 | 12 | 35906200 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | MYC HDAC6 RTCB RBMS2 WDR70 TBC1D2B TNIP1 RPSA BLZF1 SAPCD2 PDCD4 SRRT RIMKLB EIF4E2 | 8.85e-06 | 1038 | 115 | 14 | 26673895 |
| Pubmed | 1.05e-05 | 225 | 115 | 7 | 12168954 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 29741614 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20346423 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28886337 | ||
| Pubmed | The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B. | 1.08e-05 | 2 | 115 | 2 | 30791110 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23723061 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.08e-05 | 2 | 115 | 2 | 10827969 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19694741 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.08e-05 | 2 | 115 | 2 | 11245985 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24095110 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.08e-05 | 2 | 115 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.08e-05 | 2 | 115 | 2 | 23016767 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 29984790 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27153334 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.08e-05 | 2 | 115 | 2 | 24990319 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 31439038 | ||
| Pubmed | Differential roles of glial and neuronal glutamate transporters in Purkinje cell synapses. | 1.08e-05 | 2 | 115 | 2 | 16177048 | |
| Pubmed | Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation. | 1.08e-05 | 2 | 115 | 2 | 21643008 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8898078 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16647773 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14550562 | ||
| Pubmed | ZRANB3 is a structure-specific ATP-dependent endonuclease involved in replication stress response. | 1.08e-05 | 2 | 115 | 2 | 22759634 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.08e-05 | 2 | 115 | 2 | 15249644 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27690330 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 1.08e-05 | 2 | 115 | 2 | 23965409 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 1.08e-05 | 2 | 115 | 2 | 16847056 | |
| Pubmed | Chondroitin sulfate proteoglycan tenascin-R regulates glutamate uptake by adult brain astrocytes. | 1.08e-05 | 2 | 115 | 2 | 24337573 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 30693367 | ||
| Pubmed | Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. | 1.08e-05 | 2 | 115 | 2 | 26289036 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 29649454 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19745168 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.08e-05 | 2 | 115 | 2 | 21531043 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16678258 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17967977 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33096315 | ||
| Pubmed | Genetic analysis in post-mortem samples with micro-ischemic alterations. | 1.08e-05 | 2 | 115 | 2 | 28086167 | |
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 1.08e-05 | 2 | 115 | 2 | 16054936 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33712547 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26311622 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22704558 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21377452 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19666841 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14985349 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20489729 | ||
| Pubmed | 1.27e-05 | 90 | 115 | 5 | 28978906 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RTCB BAG3 WDR70 TMOD3 RPSA ZNF318 GPRIN1 DDB1 PDCD4 NKRF LRBA GOLGB1 PCNA | 1.36e-05 | 934 | 115 | 13 | 33916271 |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.56e-05 | 15 | 115 | 3 | 9726281 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.78e-05 | 560 | 115 | 10 | 21653829 | |
| Pubmed | 1.80e-05 | 339 | 115 | 8 | 37232246 | ||
| Pubmed | Cyclin B1/Cdk1 binds and phosphorylates Filamin A and regulates its ability to cross-link actin. | 1.91e-05 | 16 | 115 | 3 | 17408621 | |
| Pubmed | MYC ASNSD1 MBTD1 DNAH10 RTCB KDM5A BMS1 TMOD3 TNIP1 RPSA ZNF318 DDB1 NKRF SRRT TAF9B PCNA | 1.97e-05 | 1429 | 115 | 16 | 35140242 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ILK RTCB BAG3 TMOD3 SCRN1 EFHD2 RPSA BIRC6 DDB1 PDCD4 PPP4R3B SRRT ABI2 MAD1L1 LRBA PCNA | 2.45e-05 | 1455 | 115 | 16 | 22863883 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAAP1 RTCB KDM5A BMS1 RPSA NCLN PDCD4 NKRF ARF6 PPP4R3B TAF9B CTNNBL1 DDX3Y LRBA PCNA | 3.04e-05 | 1318 | 115 | 15 | 30463901 |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19284629 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 18403125 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32185219 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 37158894 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 12234922 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32005694 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.72e-04 | 8 | 115 | 2 | chr9q12 | |
| Cytoband | 2q24.3 | 7.29e-04 | 16 | 115 | 2 | 2q24.3 | |
| Cytoband | 1q24 | 1.15e-03 | 20 | 115 | 2 | 1q24 | |
| Cytoband | 9p13.1 | 1.66e-03 | 24 | 115 | 2 | 9p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q32 | 2.72e-03 | 110 | 115 | 3 | chr2q32 | |
| Cytoband | 2p16.1 | 2.94e-03 | 32 | 115 | 2 | 2p16.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.01e-08 | 9 | 66 | 4 | 1203 | |
| GeneFamily | EF-hand domain containing | 1.28e-06 | 219 | 66 | 8 | 863 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.93e-05 | 3 | 66 | 2 | 287 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 4.65e-04 | 9 | 66 | 2 | 1263 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-07 | 155 | 114 | 7 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-07 | 198 | 114 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-07 | 198 | 114 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 165 | 114 | 6 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-06 | 185 | 114 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-06 | 186 | 114 | 6 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.74e-06 | 187 | 114 | 6 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.01e-06 | 188 | 114 | 6 | 3e94d105ca96ceb5fdcca39a8050217913bc02da | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-05 | 196 | 114 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 198 | 114 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-05 | 199 | 114 | 6 | 7dde5c02fcae64cd2d68f607500f2a46b97851fd | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-05 | 199 | 114 | 6 | 84879280851380e5bfe6bd48b6bbf57aedf6e003 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_Tem|URO / Disease, condition lineage and cell class | 1.28e-05 | 200 | 114 | 6 | 8b7bfe6411de9528603481f6e5612cbbb8471cf6 | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.28e-05 | 200 | 114 | 6 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 123 | 114 | 5 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-05 | 149 | 114 | 5 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.23e-05 | 168 | 114 | 5 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.23e-05 | 168 | 114 | 5 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.23e-05 | 168 | 114 | 5 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 170 | 114 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 9.24e-05 | 177 | 114 | 5 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 9.49e-05 | 178 | 114 | 5 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-05 | 179 | 114 | 5 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 181 | 114 | 5 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 182 | 114 | 5 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 182 | 114 | 5 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 182 | 114 | 5 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 182 | 114 | 5 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 183 | 114 | 5 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 183 | 114 | 5 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 184 | 114 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 184 | 114 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 184 | 114 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.11e-04 | 184 | 114 | 5 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-04 | 187 | 114 | 5 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 187 | 114 | 5 | 7b24a324335c30c4b37795c43611b297274c804b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 187 | 114 | 5 | 53d41c86f57c00e6148a3eb73f42a842d78d50a1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 188 | 114 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.23e-04 | 188 | 114 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.23e-04 | 188 | 114 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 189 | 114 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | mLN-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.27e-04 | 100 | 114 | 4 | c560326f6ae5338aecdf11ef8adf04bc8769745c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 190 | 114 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 191 | 114 | 5 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 191 | 114 | 5 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 191 | 114 | 5 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | Control-PLT_1|World / Disease Group and Platelet Clusters | 1.35e-04 | 192 | 114 | 5 | f595eba81911eb860dce964f1d8269287f50d3ea | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 192 | 114 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-04 | 192 | 114 | 5 | 7bcdbd97fa8c3bfccde426d44979601226913fc3 | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-04 | 193 | 114 | 5 | 053adc7ed9f997b503e12239a684bb9f5896e10c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 193 | 114 | 5 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.42e-04 | 194 | 114 | 5 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.42e-04 | 194 | 114 | 5 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.45e-04 | 195 | 114 | 5 | 4e9513a7ea69fa9fc8e9ff2da8ef3f44e8fdc70d | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.45e-04 | 195 | 114 | 5 | a25a342380e258b784227f7298f609ccaa1f9ce7 | |
| ToppCell | Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.45e-04 | 195 | 114 | 5 | 2af46e87947c16a7c2c367637e606cfbb8a78528 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 196 | 114 | 5 | 7ce416e1809bfbb39553c28c20125790100a938d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 196 | 114 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 196 | 114 | 5 | 29246378ffb1010fe6858da756ae3d13df2306ba | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 196 | 114 | 5 | 80264c2fbd94418f981085fed7c5bdda1e6f404c | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.49e-04 | 196 | 114 | 5 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 196 | 114 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 196 | 114 | 5 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 196 | 114 | 5 | 292da8a0c052917a2f68afee9068b5b8e1544b13 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-04 | 196 | 114 | 5 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | ILEUM-inflamed-(3)_MNP|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.53e-04 | 197 | 114 | 5 | b105bad5ac85961919a654a38587d1017973c981 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-04 | 197 | 114 | 5 | 1a30747a2188a890f58d831030328986b3a4356d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 197 | 114 | 5 | dc56bb758c7c5bd151be66f8f3b7078d085f72c7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 197 | 114 | 5 | 2efb5acd56b96e5afd8d72b927f1d53cc443766f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 198 | 114 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-APOE+_Mac1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 198 | 114 | 5 | 88182ad964db88cf85b3e3a64929d07d59a923c2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 198 | 114 | 5 | 88635244a0b306d2cc50b8412fe47bb359c9cf00 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.56e-04 | 198 | 114 | 5 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Monocytes|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.56e-04 | 198 | 114 | 5 | 8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.56e-04 | 198 | 114 | 5 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 1.56e-04 | 198 | 114 | 5 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.60e-04 | 199 | 114 | 5 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 199 | 114 | 5 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-04 | 199 | 114 | 5 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 199 | 114 | 5 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 199 | 114 | 5 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.60e-04 | 199 | 114 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-04 | 199 | 114 | 5 | fa5ad81554969fffe5e779614d071d9194a7182c | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.64e-04 | 200 | 114 | 5 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 200 | 114 | 5 | 52f2a97af2d77dd068b19531dad1b3fba2601e90 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-MoAM-MoAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.64e-04 | 200 | 114 | 5 | baef622b82b262609cf5410f701ac814c20c3557 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-MoAM-MoAM-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-04 | 200 | 114 | 5 | 2e7478ddb2f09b0a14635759033c2e675b981c9f | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-04 | 200 | 114 | 5 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | mLN-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 1.64e-04 | 200 | 114 | 5 | e3f7852aaa26a9b3e626d85e40afde799e873045 | |
| Drug | SC 38249 | 4.37e-07 | 4 | 110 | 3 | CID000134834 | |
| Drug | Zonisamide | 1.17e-06 | 17 | 110 | 4 | DB00909 | |
| Drug | bepridil | 2.67e-06 | 126 | 110 | 7 | CID000002351 | |
| Drug | o-vanillin | 1.76e-05 | 11 | 110 | 3 | CID000008991 | |
| Drug | R 478 | 1.76e-05 | 11 | 110 | 3 | CID000084223 | |
| Drug | lamotrigine | 2.14e-05 | 116 | 110 | 6 | CID000003878 | |
| Drug | riluzole | 2.22e-05 | 174 | 110 | 7 | CID000005070 | |
| Drug | Phenytoin | 2.31e-05 | 2 | 110 | 2 | DB00252 | |
| Drug | flecainide | 2.43e-05 | 71 | 110 | 5 | CID000003355 | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 7142_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; HL60; HG-U133A | 4.90e-05 | 197 | 110 | 7 | 1777_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; HL60; HG-U133A | 5.05e-05 | 198 | 110 | 7 | 1560_DN | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 6206_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; HL60; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 1329_UP | |
| Drug | 1,3-dioxane | 5.87e-05 | 16 | 110 | 3 | CID000010450 | |
| Drug | bromfenacoum | BTBD8 RTCB BAG3 SCRN1 RPSA SIK3 PIP5K1C SLC1A3 ATP2C1 VWA5A TNR MMUT | 6.66e-05 | 644 | 110 | 12 | ctd:C013418 |
| Drug | cis-diammineplatinum(II | 6.92e-05 | 3 | 110 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.92e-05 | 3 | 110 | 2 | CID002750949 | |
| Drug | chlorodibromomethane | 6.92e-05 | 3 | 110 | 2 | ctd:C032707 | |
| Drug | 8N3-cADPR | 6.92e-05 | 3 | 110 | 2 | CID000127713 | |
| Drug | aminodantrolene | 6.92e-05 | 3 | 110 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 6.92e-05 | 3 | 110 | 2 | CID000093551 | |
| Drug | AC1L1TMU | 6.92e-05 | 3 | 110 | 2 | CID000035398 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.92e-05 | 3 | 110 | 2 | CID005748312 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.25e-08 | 10 | 106 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.25e-08 | 10 | 106 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 7.62e-08 | 12 | 106 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.39e-07 | 163 | 106 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 3.83e-05 | 3 | 106 | 2 | C0349788 | |
| Disease | anxiety disorder (implicated_via_orthology) | 6.60e-05 | 22 | 106 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 1.90e-04 | 6 | 106 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 2.22e-04 | 82 | 106 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 2.22e-04 | 82 | 106 | 4 | C0751111 | |
| Disease | Aura | 2.22e-04 | 82 | 106 | 4 | C0236018 | |
| Disease | Seizure, Febrile, Simple | 2.65e-04 | 7 | 106 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 2.65e-04 | 7 | 106 | 2 | C0751057 | |
| Disease | Brugada syndrome | 3.53e-04 | 8 | 106 | 2 | cv:C1142166 | |
| Disease | Febrile Convulsions | 4.53e-04 | 9 | 106 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.53e-04 | 9 | 106 | 2 | C3502809 | |
| Disease | Epilepsy | 6.55e-04 | 109 | 106 | 4 | C0014544 | |
| Disease | Tachycardia, Ventricular | 6.88e-04 | 11 | 106 | 2 | C0042514 | |
| Disease | Long QT Syndrome | 6.88e-04 | 11 | 106 | 2 | C0023976 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 9.72e-04 | 13 | 106 | 2 | C0751122 | |
| Disease | Sjogren's Syndrome | 9.72e-04 | 13 | 106 | 2 | C1527336 | |
| Disease | Brugada Syndrome 1 | 9.72e-04 | 13 | 106 | 2 | C4551804 | |
| Disease | Sicca Syndrome | 9.72e-04 | 13 | 106 | 2 | C0086981 | |
| Disease | MMR-related febrile seizures | 1.30e-03 | 15 | 106 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.48e-03 | 16 | 106 | 2 | C0393706 | |
| Disease | acute lymphoblastic leukemia | 1.75e-03 | 66 | 106 | 3 | EFO_0000220 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.88e-03 | 18 | 106 | 2 | HP_0002373 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.24e-03 | 152 | 106 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of prostate | 2.33e-03 | 20 | 106 | 2 | C0007112 | |
| Disease | blood pressure | 2.82e-03 | 22 | 106 | 2 | EFO_0004325 | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.82e-03 | 22 | 106 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | drug-induced liver injury | 3.35e-03 | 24 | 106 | 2 | EFO_0004228 | |
| Disease | Brugada Syndrome (disorder) | 3.35e-03 | 24 | 106 | 2 | C1142166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNELMEGKVQSGMGL | 121 | Q13523 | |
| LEVGLEQQAELMLKM | 2571 | Q9NR09 | |
| LKGEGLQLMNLMLRE | 331 | Q8WYA6 | |
| MVIKMIDQGLILQDG | 1201 | Q15878 | |
| IGKAEVMPVRLEMEN | 1726 | Q68DQ2 | |
| KDLEEGIQMLMGRLE | 146 | Q14406 | |
| ILKILEGDNGMDSDM | 191 | Q9H8G2 | |
| EAMVMGILKQAFDVL | 771 | Q8IYB7 | |
| LGSEDIDNQGLMMPK | 401 | Q14692 | |
| LDGVMGRILELKNEM | 76 | Q86XH1 | |
| IALAMKMGLDGLQQD | 431 | P98194 | |
| MAELQMLLEEEIPGG | 1 | Q9NYB9 | |
| MDEQELEGMLKPFGQ | 146 | Q15434 | |
| KMPVQMIGDILAAEL | 1281 | Q9NZM3 | |
| MLEEAGEVLENMLKA | 1 | Q969V3 | |
| GNVGMIMLIQVDVKL | 41 | Q8NGQ6 | |
| KAGEDRAILLGLAMM | 41 | Q9Y691 | |
| EELGGQKQRADMLEM | 461 | Q9Y6D9 | |
| ILKGMIDQISMKEAG | 436 | Q6P0N0 | |
| MKGALMEIIQLASLD | 71 | Q9H3P2 | |
| GFRVGMKLEAVDLME | 491 | Q05BQ5 | |
| GVLQLGKMLTEKAME | 61 | Q9H2G9 | |
| KMGIDISVLMGANIA | 141 | Q8N335 | |
| MIVLKMVDLNGDDLG | 281 | Q9NR71 | |
| MIGKDDSMQNLGIIP | 556 | Q2KJY2 | |
| IDEFVGDMMKDLPIL | 451 | Q5H9U9 | |
| KLLAETAGMIGVQEM | 96 | Q9NP86 | |
| NEMAELDIMGLALKL | 5301 | Q5CZC0 | |
| AMESKLLIGGRNIMD | 516 | O14782 | |
| MKLMDLDVEQLGIPE | 116 | P12004 | |
| EMLRDLNLGEMKSGV | 186 | Q53EL6 | |
| LGFQVGMKLEAVDRM | 411 | Q9Y468 | |
| AIMEEQAAELLGVKM | 171 | Q8WVE0 | |
| NMIADLLVDMLGVLA | 146 | P50851 | |
| VLKVMAIDMDEGINA | 261 | Q9Y5G1 | |
| KLGILPALEIVMGMD | 361 | Q5MIZ7 | |
| LLTNLGMIKMDVVDG | 366 | Q96RD7 | |
| AKAQLEELMMVGDLL | 1441 | P29375 | |
| LVEDDFLMKVLEGMA | 411 | O95248 | |
| MLLAMNKVEGDNISG | 341 | O60353 | |
| QAMKDLDGMDADILG | 76 | Q8TES7 | |
| RGMFAGGLKEMEQEE | 76 | Q53GT1 | |
| LIAGKIVEMEDMGVI | 296 | P43003 | |
| LNMADMYGLEGLKEV | 281 | Q5XKL5 | |
| KLDEMQEGFKMGLTL | 276 | Q9UBP9 | |
| SNMEIGMKVALEGLR | 396 | Q13418 | |
| LIAGKILEMEDMAVL | 321 | P48664 | |
| NTMEALLLEMKIGAE | 281 | Q6ZN28 | |
| LMGLDGMVLLLSVLE | 181 | Q96JQ5 | |
| EGLNKEIMMELGRIS | 516 | Q9NWL6 | |
| EMVAIGMKNGEFVIL | 1741 | Q6ZMW3 | |
| GEKVVEELNRLGMMI | 251 | Q9H4B8 | |
| AGRDGFIDLMELKLM | 106 | Q96C19 | |
| MKKLGQAMEEDLIVG | 56 | Q9UBN7 | |
| QAMEEDLIVGLQGMD | 61 | Q9UBN7 | |
| SDIDMGEIIMGNIEL | 181 | O15523 | |
| GAAMEVEVLGMAIQK | 926 | Q7Z2K8 | |
| LILAMLGEQFMVGEE | 151 | O60573 | |
| LQAIMEMGAVAADKG | 521 | O95817 | |
| MVTQLAKMLDALLEG | 2316 | Q8IVF4 | |
| AEAVAMGLLKQFEGM | 626 | Q92622 | |
| MNIPLGEKVMLDIVA | 1 | Q5SY68 | |
| KEEEKLMIRGLGDIM | 2136 | Q92736 | |
| FMLLLEKEEQMDGTV | 281 | Q16531 | |
| LMLNGEEVEETELMG | 436 | Q16531 | |
| MLRLKELGINNMGEL | 286 | Q6UXK5 | |
| KLAGQEGLVEMVLLM | 436 | Q53GL7 | |
| EMLLMLLAAGGDDEL | 446 | Q9UHC7 | |
| GDRAKALDIMIPMVQ | 366 | Q99683 | |
| MSGALDVLQMKEEDV | 1 | P08865 | |
| IPMNAKDLEEALEMG | 161 | Q9Y3I0 | |
| ALVMAQILKDMGITE | 16 | Q9HBM6 | |
| GNALIEVGESMKLMA | 111 | Q99963 | |
| LLMKGEGEVKLNMAI | 2671 | Q8NF91 | |
| EGEGQGPLIKLEMMI | 751 | Q14DG7 | |
| MEKILQMAEGIDIGE | 1 | O15226 | |
| EAQGLMTAVGQMLDK | 1201 | Q5VVP1 | |
| GVDIPLKQLMVIGMD | 731 | Q8TC59 | |
| ADQLEMVTELLGGDM | 96 | P01106 | |
| KDLDFMQDMPEGLLL | 276 | O60331 | |
| RDIEEGNVKMLGMQI | 1086 | Q9BQS7 | |
| AQGLMTAVGQMLDEK | 1206 | Q8IWB4 | |
| VLGESGEMDALKIQM | 1861 | Q14524 | |
| NEDVLLAMEDMGLDK | 346 | Q9Y2K2 | |
| LGESGEMDALRIQME | 1861 | Q9NY46 | |
| MFGDINLTLGMLNKE | 11 | Q7Z745 | |
| DMVELMLEEKGVQLD | 451 | Q5JTZ9 | |
| TMLELEKQGLEAMEE | 371 | Q12765 | |
| LGESGEMDALRIQME | 1876 | P35498 | |
| IVKMLDAAVIKMEGG | 246 | Q9BXP5 | |
| GAGKIGRMIAEEIME | 491 | O00327 | |
| SLEVMLMLVKAGADQ | 146 | A6NHY2 | |
| GNGDIDIMSLKRMLE | 61 | P55008 | |
| AEEIVDGNLKMTLGM | 126 | Q08043 | |
| NKEMRILMLGLDAAG | 11 | P62330 | |
| GIEMEKVMQELGKSL | 171 | Q9NQ89 | |
| GIKMLGELLEESQME | 41 | Q15025 | |
| AQGLMTAVGQMLDEK | 1206 | Q5VYP0 | |
| NDIKDVGQMLMGKLA | 201 | Q1ZZU3 | |
| DLGNQLLGLKGVMEM | 411 | Q8IWX7 | |
| MEALGFLKLEVNGPM | 1 | P24557 | |
| AQGLMTAVGQMLDEK | 1206 | Q5TZJ5 | |
| EQEKEVLLQGLEMMA | 236 | Q86UD0 | |
| AQGLMTAVGQMLDEK | 1206 | Q5VU36 | |
| RMGKEEELLMINGLG | 2031 | Q15413 | |
| MVGKPVNFMEEDILG | 126 | Q9NW82 | |
| LGESGEMDALRIQME | 1866 | Q99250 | |
| MGADGETVVLKNMLI | 1 | Q92752 | |
| EGLIFLMMLQKGGEE | 61 | A0A0B4J273 | |
| AKILGMSLEEIMAAQ | 701 | O00534 | |
| LGMDVCGIDLLMKDD | 256 | Q9ULI2 | |
| EMAEGKNAILIGMSQ | 41 | Q9BZ71 | |
| VIVMEDMLKDFLLGE | 761 | A3KMH1 | |
| SKVGELNEQLGMLME | 431 | Q9UPU7 | |
| ALDLLAGGMMPEEVK | 2126 | Q5VUA4 | |
| QLGTAVELEMAKMLE | 296 | Q9NYL9 | |
| MVADEMGLGKTIQAI | 56 | Q5FWF4 | |
| EVLDQKEMKQMEGEG | 591 | Q14789 | |
| AALKLINEIEEMGGM | 441 | P22033 | |
| INEIEEMGGMAKAVA | 446 | P22033 | |
| VMAGKVEMTLEILNE | 1961 | Q9NZM1 |